Juan Ángel Patiño-Galindo

Juan Ángel Patiño-Galindo

Auto-generated profile, based on publicly available information

Juan Ángel Patiño-Galindo

Unidad Mixta Infección y Salud Pública FISABIO-CSISP/Universidad de Valencia-I2SysBio, Valencia, 46180, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Virus Evolution
Verified
Journal Article
Open access
PDF file
JPJuan Ángel Patiño-Galindo
Juan Ángel Patiño-Galindo
FGFernando González-Candelas
Fernando González-Candelas
HIV-1M causes most infections in the AIDS pandemic. Its genetic diversity is defined by nine pure subtypes and more than sixty recombinant forms. We have performed a comparative analysis of the evolutionary rate of five pure subtypes (A1, B, C, D, and G) and two circulating recombinant forms (CRF01_AE and CRF02 AG) using data obtained from nearly complete genome coding sequences. Times to the most recent common ancestor (tMRCA) and substitution rates of these HIV genomes, and their genomic partitions, were estimated by Bayesian coalescent analyses. Genomic substitution rate estimates were compared between the HIV-1 datasets analyzed by means of randomization tests. Significant differences in the rate of evolution were found between subtypes, with subtypes C and A1 and CRF01_AE displaying the highest rates. On the other hand, CRF02_AG and subtype D were the slowest evolving types. Using a different molecular clock model for each genomic partition led to more precise tMRCA estimates than when linking the same clock along the HIV genome. Overall, the earliest tMRCA corresponded to subtype A1 (median = 1941, 95% HPD = 1943–55), whereas the most recent tMRCA corresponded to subtype G and CRF01_AE subset 3 (median = 1971, 95% HPD = 1967–75 and median = 1972, 95% HPD = 1970–75, respectively). These results suggest that both biological and epidemiological differences among HIV-1M subtypes are reflected in their evolutionary dynamics. The estimates obtained for tMRCAs and substitution rates provide information that can be used as prior distributions in future Bayesian coalescent analyses of specific HIV-1 subtypes/CRFs and genes.

1 April 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
JPJuan Ángel Patiño-Galindo
Juan Ángel Patiño-Galindo
KSKarina Alejandra Salvatierra
Karina Alejandra Salvatierra
FGFernando González-Candelas
Fernando González-Candelas
FLF. Xavier Lopez-Labrador
F. Xavier Lopez-Labrador
There is no comprehensive study available on the natural hepatitis C virus (HCV) polymorphism in sites associated with resistance including all viral genotypes which may present variable susceptibilities to particular direct-acting antivirals (DAAs). This study aimed to analyze the frequencies, genetic barriers, and evolutionary histories of naturally occurring resistance-associated variants (RAVs) in the six main HCV genotypes. A comprehensive analysis of up to 103 RAVs was performed in 2,901, 2,216, and 1,344 HCV isolates for the NS3, NS5A, and NS5B genes, respectively. We report significant intergenotypic differences in the frequencies of natural RAVs for these three HCV genes. In addition, we found a low genetic barrier for the generation of new RAVs, irrespective of the viral genotype. Furthermore, in 1,126 HCV genomes, including sequences spanning the three genes, haplotype analysis revealed a remarkably high frequency of viruses carrying more than one natural RAV to DAAs (53% of HCV-1a, 28.5% of HCV-1b, 67.1% of HCV-6, and 100% of genotype 2, 3, 4, and 5 haplotypes). With the exception of HCV-1a, the most prevalent haplotypes showed RAVs in at least two different viral genes. Finally, evolutionary analyses revealed that, while most natural RAVs appeared recently, others have been efficiently transmitted over time and cluster in well-supported clades. In summary, and despite the observed high efficacy of DAA-based regimens, we show that naturally occurring RAVs are common in all HCV genotypes and that there is an overall low genetic barrier for the selection of resistance mutations. There is a need for natural DAA resistance profiling specific for each HCV genotype.

14 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JPJuan Ángel Patiño-Galindo
Juan Ángel Patiño-Galindo
MTManoli Torres-Puente
Manoli Torres-Puente
MBMaría Alma Bracho
María Alma Bracho
IAIgnacio Alastrué
Ignacio Alastrué
AJAmparo Juan
Amparo Juan
FGFernando González-Candelas
Fernando González-Candelas
HIV infections are still a very serious concern for public heath worldwide. We have applied molecular evolution methods to study the HIV-1 epidemics in the Comunidad Valenciana (CV, Spain) from a public health surveillance perspective. For this, we analysed 1804 HIV-1 sequences comprising protease and reverse transcriptase (PR/RT) coding regions, sampled between 2004 and 2014. These sequences were subtyped and subjected to phylogenetic analyses in order to detect transmission clusters. In addition, univariate and multinomial comparisons were performed to detect epidemiological differences between HIV-1 subtypes, and risk groups. The HIV epidemic in the CV is dominated by subtype B infections among local men who have sex with men (MSM). 270 transmission clusters were identified (>57% of the dataset), 12 of which included ≥10 patients; 11 of subtype B (9 affecting MSMs) and one (n = 21) of CRF14, affecting predominately intravenous drug users (IDUs). Dated phylogenies revealed these large clusters to have originated from the mid-80s to the early 00 s. Subtype B is more likely to form transmission clusters than non-B variants and MSMs to cluster than other risk groups. Multinomial analyses revealed an association between non-B variants, which are not established in the local population yet, and different foreign groups.

1 August 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
JGJuan Angel Patiño Galindo
Juan Angel Patiño Galindo
MTManoli Torres-Puente
Manoli Torres-Puente
CGConcepción Gimeno
Concepción Gimeno
EOEnrique Ortega
Enrique Ortega
DNDavid Navarro
David Navarro
FGFernando González-Candelas
Fernando González-Candelas

2 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJuan Ángel Patiño-Galindo
Juan Ángel Patiño-Galindo
MTManoli Torres-Puente
Manoli Torres-Puente
MBMaria Alma Bracho
Maria Alma Bracho
IAIgnacio Alastrué
Ignacio Alastrué
AJAmparo Juan
Amparo Juan
FGFernando González-Candelas
Fernando González-Candelas
We describe and characterize an exceptionally large HIV-1 subtype B transmission cluster occurring in the Comunidad Valenciana (CV, Spain). A total of 1806 HIV-1 protease-reverse transcriptase (PR/RT) sequences from different patients were obtained in the CV between 2004 and 2014. After subtyping and generating a phylogenetic tree with additional HIV-1 subtype B sequences, a very large transmission cluster which included almost exclusively sequences from the CV was detected (n = 143 patients). This cluster was then validated and characterized with further maximum-likelihood phylogenetic analyses and Bayesian coalescent reconstructions. With these analyses, the CV cluster was delimited to 113 patients, predominately men who have sex with men (MSM). Although it was significantly located in the city of Valencia (n = 105), phylogenetic analyses suggested this cluster derives from a larger HIV lineage affecting other Spanish localities (n = 194). Coalescent analyses estimated its expansion in Valencia to have started between 1998 and 2004. From 2004 to 2009, members of this cluster represented only 1.46% of the HIV-1 subtype B samples studied in Valencia (n = 5/143), whereas from 2010 onwards its prevalence raised to 12.64% (n = 100/791). In conclusion, we have detected a very large transmission cluster in the CV where it has experienced a very fast growth in the recent years in the city of Valencia, thus contributing significantly to the HIV epidemic in this locality. Its transmission efficiency evidences shortcomings in HIV control measures in Spain and particularly in Valencia.

1 June 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
JPJ.A. Patiño-Galindo
J.A. Patiño-Galindo
MTMichael M. Thomson
Michael M. Thomson
LPLucía Pérez-Álvarez
Lucía Pérez-Álvarez
EDElena Delgado
Elena Delgado
MCMaría Teresa Cuevas
María Teresa Cuevas
FGFernando González-Candelas
Fernando González-Candelas